Es gab 50 kürzliche Insider-Transaktionen für PhaseBio Pharmaceuticals, Inc. (PHAS), darunter 35 Käufe und 13 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.07M und die gesamten Insider-Verkäufe auf $421.77K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Harrigan Edmund, Loewy Caroline M, Hutson Nancy J. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PHAS
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2023-05-19 |
Harrigan Edmund |
Director |
Optionsausübung |
3,750 |
- |
- |
- |
| 2023-05-19 |
Loewy Caroline M |
Director |
Optionsausübung (Verkauf) |
3,750 |
- |
- |
- |
| 2023-05-19 |
Hutson Nancy J |
Director |
Optionsausübung (Verkauf) |
3,750 |
- |
- |
- |
| 2023-05-19 |
Van Den Broek Richard |
Director |
Optionsausübung (Verkauf) |
3,750 |
- |
- |
- |
| 2023-05-19 |
Thorp Clay |
Director |
Optionsausübung |
3,750 |
- |
- |
- |
| 2023-05-19 |
Humphries William D. |
Director |
Optionsausübung (Verkauf) |
2,538 |
- |
- |
- |
| 2023-05-19 |
Sapir Alex |
Director |
Optionsausübung (Verkauf) |
3,750 |
- |
- |
- |
| 2022-10-25 |
New Enterprise Associates 13 Lp |
Director |
Informierter Verkauf |
1,784,109 |
$0.15 |
$262.26K |
4,857,525 |
| 2022-05-20 |
Mow Jonathan P |
Chief Executive Officer |
RSU-Zuteilung |
10,918 |
$0.68 |
$7.44K |
132,502 |
| 2022-05-20 |
Sharp John P |
Chief Financial Officer |
RSU-Zuteilung |
6,026 |
$0.68 |
$4.11K |
65,767 |
| 2022-05-20 |
Arnold Susan Elizabeth |
SVP, Technical Operations |
RSU-Zuteilung |
10,917 |
$0.68 |
$7.44K |
41,236 |
| 2022-05-20 |
Hanson Kristopher |
SVP and General Counsel |
RSU-Zuteilung |
4,831 |
$0.68 |
$3.29K |
8,463 |
| 2022-05-20 |
Burkhardt Glen |
SVP of Human Resources |
Informierter Verkauf |
11,248 |
$0.79 |
$8.89K |
- |
| 2022-05-20 |
Birchall Jonathan |
Chief Commercial Officer |
RSU-Zuteilung |
20,000 |
$0.68 |
$13.63K |
20,000 |
| 2022-05-19 |
Harrigan Edmund |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Loewy Caroline M |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Hutson Nancy J |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Van Den Broek Richard |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Thorp Clay |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Humphries William D. |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Sapir Alex |
Director |
RSU-Zuteilung |
3,750 |
- |
- |
3,750 |
| 2022-05-19 |
Humphries William D. |
Director |
RSU-Zuteilung |
2,538 |
- |
- |
2,538 |
| 2022-02-24 |
Mow Jonathan P |
Chief Executive Officer |
RSU-Zuteilung |
82,500 |
- |
- |
82,500 |
| 2022-02-24 |
Sharp John P |
Chief Financial Officer |
RSU-Zuteilung |
24,750 |
- |
- |
24,750 |
| 2022-02-24 |
Lee John Sang |
Chief Medical Officer |
RSU-Zuteilung |
24,750 |
- |
- |
24,750 |
| 2022-02-24 |
Arnold Susan Elizabeth |
SVP, Technical Operations |
RSU-Zuteilung |
18,750 |
- |
- |
18,750 |
| 2022-02-24 |
Hanson Kristopher |
VP, Head of Legal |
RSU-Zuteilung |
18,750 |
- |
- |
18,750 |
| 2022-02-24 |
Burkhardt Glen |
VP, Human Resources |
RSU-Zuteilung |
18,750 |
- |
- |
18,750 |
| 2022-02-24 |
Birchall Jonathan |
Chief Commercial Officer |
RSU-Zuteilung |
11,250 |
- |
- |
11,250 |
| 2021-11-19 |
Mow Jonathan P |
Chief Executive Officer |
RSU-Zuteilung |
5,623 |
$2.01 |
$11.3K |
172,473 |
| 2021-11-19 |
Sharp John P |
Chief Financial Officer |
RSU-Zuteilung |
2,017 |
$2.01 |
$4.05K |
59,741 |
| 2021-11-19 |
Arnold Susan Elizabeth |
SVP, Technical Operations |
RSU-Zuteilung |
2,559 |
$2.01 |
$5.14K |
30,319 |
| 2021-11-19 |
Hanson Kristopher |
VP, Head of Legal |
RSU-Zuteilung |
1,545 |
$2.01 |
$3.11K |
3,632 |
| 2021-11-19 |
Burkhardt Glen |
VP, Human Resources |
Informierter Verkauf |
5,766 |
$2.37 |
$13.67K |
- |
| 2021-11-08 |
Hutson Nancy J |
Director |
Optionsausübung (Verkauf) |
7,400 |
$3.15 |
$23.31K |
- |
| 2021-11-08 |
Birchall Jonathan |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2021-11-08 |
Birchall Jonathan |
Chief Commercial Officer |
RSU-Zuteilung |
250,000 |
$3.37 |
$842.5K |
250,000 |
| 2021-11-05 |
Hutson Nancy J |
Director |
Optionsausübung (Verkauf) |
24,860 |
$2.26 |
$56.18K |
2,256 |
| 2021-11-03 |
Mow Jonathan P |
Chief Executive Officer |
Optionsausübung (Verkauf) |
20,000 |
$1.24 |
$24.8K |
108,767 |
| 2021-11-03 |
Sharp John P |
Chief Financial Officer |
Optionsausübung |
7,500 |
$1.68 |
$12.6K |
57,724 |
| 2021-09-14 |
Humphries William D. |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-09-14 |
Humphries William D. |
Director |
RSU-Zuteilung |
28,000 |
$2.80 |
$78.4K |
28,000 |
| 2021-08-27 |
Mow Jonathan P |
Chief Executive Officer |
Optionsausübung (Verkauf) |
20,000 |
$1.24 |
$24.8K |
128,767 |
| 2021-08-18 |
Thorp Clay |
Director |
Informierter Kauf |
10,000 |
$3.00 |
$30K |
32,943 |
| 2021-08-18 |
Hutson Nancy J |
Director |
Informierter Kauf |
3,000 |
$3.08 |
$9.24K |
4,000 |
| 2021-08-18 |
Hutson Nancy J |
Director |
Informierter Kauf |
3,000 |
$3.08 |
$9.24K |
4,000 |
| 2021-08-03 |
Sharp John P |
Chief Financial Officer |
RSU-Zuteilung |
7,500 |
$1.68 |
$12.6K |
50,224 |
| 2021-08-03 |
Sharp John P |
Chief Financial Officer |
Optionsausübung |
7,500 |
$1.68 |
$12.6K |
50,224 |
| 2021-07-12 |
Arnold Susan Elizabeth |
VP, Preclinical and Chem |
Optionsausübung (Verkauf) |
4,519 |
$1.74 |
$7.86K |
- |
| 2021-07-12 |
Arnold Susan Elizabeth |
VP, Preclinical and Chem |
RSU-Zuteilung |
4,519 |
$1.74 |
$7.86K |
27,760 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
